Compass Therapeutics Inc. (CMPX) Annual Income Statement (USD)
CMPX Quarterly Financials (USD)
Frequently Asked Questions About Compass Therapeutics Inc. (CMPX) Stock
Compass Therapeutics Inc.'s (CMPX) last reported annual revenue was USD 0.00.
Compass Therapeutics Inc.'s (CMPX) annual revenue growth rate based on the revenue reported in the past 5 years is : N/A
Compass Therapeutics Inc.'s(CMPX) is not profitable as of its last reported annual financials.
The net profit margin for Compass Therapeutics Inc.'s(CMPX) from its laster reported year is N/A
The return on equity (ROE) for Compass Therapeutics Inc.'s(CMPX) from its last reported annual financials is : -25.74%
The return on assets (ROA) for Compass Therapeutics Inc.'s(CMPX) from its last reported annual financials is : -17.66%
The return on invested capital (ROIC) for Compass Therapeutics Inc.'s(CMPX) from its last reported annual financials is : -30.51%
The Debt to Equity ratio for Compass Therapeutics Inc.'s(CMPX) from its last reported annual financials is : 0.00%
The dividend yield for Compass Therapeutics Inc.'s(CMPX) from its laster reported year is 0.00%
Compass Therapeutics Inc.'s(CMPX) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for CMPX !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
